“Smart investors will look for biotech stocks that have drug pipelines full of good prospects, as well as balance sheets strong enough to withstand any unforeseen problems,” acknowledges the author […]read more
Having Posted Tremendous Gains In Recent Months, Are Either Of These 2 Small-Cap Biotech Stocks Buys?
“This year didn’t start out with a bang for these two biotechs, but their performances over the past few months have been breathtaking,” observes the author of today’s article in […]read more
Investors looking for a post-election idea may want to consider the ETF highlighted in today’s article, which tracks an index “comprised of small- and mid-cap stocks of biotechnology companies that […]read more
Today’s article highlights a plethora of new stocks to watch in the biotech, tech, cleantech, psychedelics and cannabis spaces, among others. In regards to the biotech names, the author notes […]read more
“With the number of new drugs and biologics going up day by day, there has never been a better time to invest in biotech stocks,” declares the author of today’s […]read more
Despite biotech’s outperformance year-to-date, the authors of today’s article still see the industry as attractive – and they outline three key strategic themes driving their investment thesis for biotech (and […]read more
After an initial analysis of clinical data back in May failed to demonstrate a statistically significant impact on the biomarkers associated with the disease, a re-analysis has found that the […]read more